Azithromycin-based Extended-Spectrum Antibiotic Prophylaxis for Cesarean: Role of Placental Colonization with Genital Ureaplasmas and Mycoplasmas

Akila Subramaniam; Ken B. Waites; Victoria C. Jauk; Joseph R. Biggio; Amelia L. M. Sutton; Jeff M. Szychowski; William W. Andrews; Alan T. N. Tita

doi:10.1055/s-0038-1675766

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2019; 36(10): 1002-1008
DOI: 10.1055/s-0038-1675766

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Azithromycin-based Extended-Spectrum Antibiotic Prophylaxis for Cesarean: Role of Placental Colonization with Genital Ureaplasmas and Mycoplasmas

Akila Subramaniam

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

,

Ken B. Waites

²Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama

,

Victoria C. Jauk

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

,

Joseph R. Biggio

³Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health System, New Orleans, Louisiana

,

Amelia L. M. Sutton

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

,

Jeff M. Szychowski

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

,

William W. Andrews

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

,

Alan T. N. Tita

¹Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama

› Institutsangaben

Abstract

Objective To explore whether the effect of azithromycin (AZI) on postcesarean infections varied by the presence/absence of genital mycoplasmataceae placental colonization.

Study Design This was a single-center substudy of multicenter double-blind C/SOAP (Cesarean Section Optimal Antibiotic Prophylaxis) trial of women randomized to AZI or placebo (+cefazolin) antibiotic prophylaxis at cesarean. Chorioamnion/placenta specimens were tested for genital mycoplasmataceae colonization by polymerase chain reaction. Primary outcome was a composite of endometritis, wound infection, or other infections up to 6 weeks postpartum. Analysis was intent-to-treat; logistic regression was used to evaluate interactions between treatment assignment (AZI/placebo) and the presence/absence of mycoplasmataceae and to quantify effects of AZI in analyses stratified by the presence/absence of these microorganisms.

Results Specimens from 613 women (303 AZI and 310 placebo) were evaluated. Baseline characteristics were similar between groups, and approximately 1/3 (30.3%) had mycoplasmataceae placental/chorioamnion colonization. There was no evidence of effect modification (p _interaction = 0.79) between treatment assignment and the presence/absence of organisms. Stratified analyses showed fewer events in the AZI group in the presence (odds ratio [OR]: 0.42; 95% confidence interval [CI]: 0.17–1.01) and absence (OR: 0.49; 95% CI: 0.24–1) of mycoplasmataceae. Results were similar with endometritis/wound infections and with ureaplasmas/mycoplasmas considered separately.

Conclusion The reduction in postcesarean infection with AZI does not vary based on the presence or absence of genital mycoplasmataceae placental colonization.

Keywords

antibiotic prophylaxis - azithromycin - cesarean - infection - ureaplasmas

Volltext

Referenzen

References
1 Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 2003; 101 (02) 289-296
2 Gibbs RS. Clinical risk factors for puerperal infection. Obstet Gynecol 1980; 55 (5, Suppl): 178S-184S
3 Thigpen BD, Hood WA, Chauhan S. , et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol 2005; 192 (06) 1864-1868
4 Costantine MM, Rahman M, Ghulmiyah L. , et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008; 199 (03) 301.e1-301.e6
5 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 120: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011; 117 (06) 1472-1483
6 Tita ATN, Szychowski JM, Boggess K. , et al; C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375 (13) 1231-1241
7 Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth JC, Cassell GH. Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum. Obstet Gynecol 1995; 85 (04) 509-514
8 Roberts S, Maccato M, Faro S, Pinell P. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993; 81 (03) 383-386
9 Zithromax® (azithromycin for injection). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/50733s5lbl.pdf . Accessed February 2018
10 Waites KB, Taylor-Robinson D. Mycoplasma and ureaplasma. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry M, Warnock DW. , eds. Manual of Clinical Microbiology. 10th ed. Washington, DC: ASM Press; 2011: 970-985
11 Xiao L, Glass JI, Paralanov V. , et al. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol 2010; 48 (08) 2715-2723
12 Svenstrup HF, Jensen JS, Björnelius E, Lidbrink P, Birkelund S, Christiansen G. Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium. J Clin Microbiol 2005; 43 (07) 3121-3128
13 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2018; 132: e103-e119
14 Waites K, Lysnyanski I, Bébéar C. Emerging antimicrobial resistance in mycoplasmas of humans and animals. In: Browning GF, Citti C. , eds. Mollicutes: Molecular Biology and Pathogenesis. Norfolk: Caister Academic Press; 2014: 289-322
15 Andrews WW, Hauth JC, Cliver SP, Savage K, Goldenberg RL. Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. Obstet Gynecol 2003; 101 (06) 1183-1189
16 Tita AT, Hauth JC, Grimes A, Owen J, Stamm AM, Andrews WW. Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis. Obstet Gynecol 2008; 111 (01) 51-56
17 Tita AT, Owen J, Stamm AM, Grimes A, Hauth JC, Andrews WW. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. Am J Obstet Gynecol 2008; 199 (03) 303.e1-303.e3
18 Pitt C, Sanchez-Ramos L, Kaunitz AM. Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. Obstet Gynecol 2001; 98 (5 Pt 1): 745-750
19 Ward E, Duff P. A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study. Am J Obstet Gynecol 2016; 214 (06) 751.e1-751.e4
20 Sutton AL, Acosta EP, Larson KB, Kerstner-Wood CD, Tita AT, Biggio JR. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. Am J Obstet Gynecol 2015; 212 (06) 812.e1-812.e6
21 Retsema J, Girard A, Schelkly W. , et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987; 31 (12) 1939-1947